The role of exosome in autoimmune connective tissue disease

References

• Trams EG, Lauter CJ, Salem N, Jr, et al. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta. 1981;645:63–70.
   PubMed Web of Science ®Google Scholar
• Lin J, Li J, Huang B, et al. Exosomes: novel biomarkers for clinical diagnosis. Sci World J. 2015;2015:1.
   Google Scholar
• Zhang X, Yuan X, Shi H, et al. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8:83.
   PubMed Web of Science ®Google Scholar
• Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adh Migr. 2007;1:156–158.
   PubMed Web of Science ®Google Scholar
• Altintas A, Cil T, Pasa S, et al. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin’s and Non-Hodgkin’s lymphoma: a single center experience. Minerva Med. 2008;99:7–14.
   PubMedGoogle Scholar
• Jin L, Pahuja KB, Wickliffe KE, et al. Ubiquitin-dependent regulation of COPII coat size and function. Nature. 2012;482:495–500.
   PubMed Web of Science ®Google Scholar
• Söllner T, Whiteheart SW, Brunner M, et al. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993;362:318–324.
   PubMed Web of Science ®Google Scholar
• Kaeser PS, Deng L, Wang Y, et al. RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell. 2011;144:282–295.
   PubMed Web of Science ®Google Scholar
• Chlebowski A, Lubas M, Jensen TH, et al. RNA decay machines: the exosome. Biochim Biophys Acta. 2013;1829:552–560.
   PubMed Web of Science ®Google Scholar
• Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581–593.
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066–27125.
   PubMed Web of Science ®Google Scholar
• Duarte C, Couto M, Ines L, et al. Epidemiology of systemic lupus erythematosus. In: Lahita RG, Tsokos G, Buyon J, Koike T, editors. Systemic lupus erythematosus. 5th ed. London: Elsevier; 2011. p. 673–696.
   Google Scholar
• Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110–2121.
   PubMed Web of Science ®Google Scholar
• Li T, Carls GS, Panopalis P, et al. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population. Arthritis Rheum. 2009;61:755–763.
   PubMedGoogle Scholar
• Ortega LM, Schultz DR, Lenz O, et al. Review: lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. Lupus. 2010;19:557–574.
   PubMed Web of Science ®Google Scholar
• Lee JY, Park JK, Lee EY, et al. Circulating exosomes from patients with systemic lupus erythematosus induce an proinflammatory immune response. Arthritis Res Ther. 2016;18:264.
   PubMed Web of Science ®Google Scholar
• Solé C, Cortés-Hernández J, Felip ML, et al. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. Nephrol Dial Transplant. 2015;30:1488–1496.
   PubMed Web of Science ®Google Scholar
• Ichii O, Otsuka-Kanazawa S, Horino T, et al. Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS One. 2014;9:e110383.
   PubMed Web of Science ®Google Scholar
• Lu J, Kwan BC, Lai FM, et al. Glomerular and tubulo interstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton). 2012;17:346–351.
   PubMed Web of Science ®Google Scholar
• Ostergaard O, Nielsen CT, Iversen LV, et al. Unique protein signature of circulating microparticles in systemic lupus erythematosus. Arthritis Rheum. 2013;65:2680–2690.
   PubMedGoogle Scholar
• Cloutier N, Paré A, Farndale RW, et al. Platelets can enhance vascular permeability. Blood. 2012;120:1334–1343.
   PubMed Web of Science ®Google Scholar
• Salvi V, Gianello V, Busatto S, et al. Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7. JCI Insight. 2018;3:pii: 98204.
   PubMed Web of Science ®Google Scholar
• Figueroa FE, Cuenca Moreno J, La Cava A. Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors. Expert Opin Drug Discov. 2014;9:555–566.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341–345.
   PubMed Web of Science ®Google Scholar
• Zhou JJ, Wang F, Xu Z, et al. Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis. J Biol Chem. 2014;289:19269–19275.
   PubMed Web of Science ®Google Scholar
• Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000;12:475–481.
   PubMed Web of Science ®Google Scholar
• Pagnini I, Vitale A, Selmi C, et al. Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms. Clin Rev Allergy Immunol. 2017;52:34–44.
   PubMed Web of Science ®Google Scholar
• Vandergheynst F, Ocmant A, Sordet C, et al. Anti-pm/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin Exp Rheumatol. 2006;24:129–133.
   PubMed Web of Science ®Google Scholar
• Mahler M, Raijmakers R. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights. Autoimmun Rev. 2007;6:432–437.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Ramos R, Gonz Lez-Díaz V, Pacheco-Tovar MG, et al. A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies. Reumatismo. 2008;60:296–300.
   PubMedGoogle Scholar
• Uitto J, Kouba D. Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci. 2000;24:S60–S69.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Jinnin M, Harada M, et al. Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts. J Dermatol Sci. 2016;84:30–39.
   PubMed Web of Science ®Google Scholar
• Mohan C, Assassi S. Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? Bmj. 2015;351:h5079.
   PubMed Web of Science ®Google Scholar
• Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol. 2012;83:1484–1494.
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–166.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou Y, Lu J, et al. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Med Oncol. 2014;31:148–155.
   PubMed Web of Science ®Google Scholar
• Song J, Kim D, Han J, et al. PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med. 2015;15:121–126.
   PubMed Web of Science ®Google Scholar
• Skriner K, Adolph K, Jungblut PR, et al. Association of citrullinated proteins with synovial exosomes. Arthritis Rheum. 2006;54:3809–3814.
   PubMed Web of Science ®Google Scholar
• Yang C, Robbins PD. Immunosuppressive exosomes: a new approach for treating arthritis. Int J Rheumatol. 2012;2012;573528.
   PubMedGoogle Scholar
• Cai Z, Zhang W, Yang F, et al. Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Res. 2012;22:607–610.
   PubMed Web of Science ®Google Scholar
• Schorey JS, Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic. 2008;9:871–881.
   PubMed Web of Science ®Google Scholar
• Bianco NR, Kim SH, Morelli AE, et al. Modulation of the immune response using dendritic cell-derived exosomes. Methods Mol Biol. 2007;380:443–455.
   PubMedGoogle Scholar
• Ostman S, Taube M, Telemo E. Tolerosome-induced oral tolerance is MHC dependent. Immunology. 2009;116:464–476.
   Google Scholar
• Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, et al. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum. 2005;52:1517–1521.
   PubMed Web of Science ®Google Scholar
• Routsias JG, Tzioufas AG. Autoimmune response and target autoantigens in Sjogren's syndrome. Eur J Clin Invest. 2010;40:1026–1036.
   PubMed Web of Science ®Google Scholar
• Bullerdiek J, Flor I. Exosome-delivered microRNAs of "chromosome 19 microRNA cluster" as immunomodulators in pregnancy and tumorigenesis. Mol Cytogenet. 2012;5:27.
   PubMed Web of Science ®Google Scholar
• Michael A, Bajracharya SD, Yuen PS, et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2010;16:34–38.
   PubMed Web of Science ®Google Scholar
• Alevizos I, Alexander S, Turner RJ, et al. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum. 2011;63:535–544.
   PubMed Web of Science ®Google Scholar